A method of treating angiogenesis-implicated disorders by selecting a subject predisposed to an angiogenesis-implicated disorder and then administering an effective amount of an endogenous aryl hydrocarbon receptor ligand or its analogs according to a formula as disclosed herein is disclosed.

 
Web www.patentalert.com

> Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same

~ 00326